Six days after the World Health Organization officially declared COVID-19 a global pandemic on March 11, 2020, Shafique Virani, M.D., landed a brand new job. Following a two-year stint leading a couple of subsidiaries of BridgeBio, the Roche-Genentech alum jumped to Recursion Pharmaceuticals to be the chief corporate development officer of the AI-driven drug discovery company. Roughly […]

Well into year three of the pandemic, we face a patchwork reality. Parts of the world resemble pre-COVID-19 days as people increasingly travel, leave home for work, and put their masks aside. At the same time, countries in Asia and Europe are battling surges fueled by the BA.2 Omicron sub-variant and US cases are rising […]

The rare disease community is intuitive and sensitive, which is why those in this space need to be hyperaware of the pulse of patients because that will guide the next steps. As the liaison between Catalyst Pharmaceuticals, which focuses on the ultra-rare Lambert-Eaton Myasthenic Syndrome (LEMS), and the LEMS community, I know firsthand the importance […]